Debunking Sepsis Myths – Episode 1
The first episode of The Michael Rothman Podcast challenges widely repeated statistics about sepsis, arguing that many sepsis-attributed hospital deaths are primarily driven by underlying chronic conditions. The episode questions the validity of claims that treatment delays dramatically increase mortality, encouraging a more nuanced understanding of sepsis in clinical settings.
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Promoted content from The Michael Rothman Podcast on MarketScale.
Key takeaways
Sepsis is often cited as causing nearly a third of hospital deaths, but many of those deaths are primarily due to chronic underlying conditions.
Commonly repeated statistics about sepsis mortality and treatment delays may be overstated or misattributed.
A more accurate understanding of sepsis requires distinguishing it from deaths where it is a secondary rather than primary factor.
Free workspace
Turn your Healthcare expertise into content.
Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.
In the first episode of
, we address misconceptions about sepsis in healthcare. Although it’s often claimed that sepsis accounts for nearly a third of hospital deaths, many of these deaths are linked to chronic conditions with sepsis as a secondary factor. The frequently cited statistic that delays in treating sepsis increase mortality by 7% per hour mainly applies to severe cases like septic shock. This episode emphasizes focusing resources more effectively to improve hospital mortality rates and patient care, setting the stage for future discussions on optimizing healthcare strategies.
Part of this channel
The Michael Rothman Podcast
Data science meets clinical medicine with Dr. Michael Rothman.
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
About the author
